SEC
ends
Original fundamental research starts and ENDS here.
Sectors
Tags
Blog
Search
LOW
30 filings
Timeline
Columns
Start Research
8-K Categories
2025
Q4
3 filings
Nov
Q3 2025 Results
Rev $20.8B (+3.2% YoY), EPS $2.88 (-3.7% YoY)
10-Q
Nov
Q3 Earnings
Q3 2025 results for quarter ended Oct 31, 2025
8-K
Oct
Acquired Foundation Building Materials
$8.8B cash deal completed
8-K
Q3
5 filings
Sep
Debt Offering
$5B notes issued, rates 3.95%-4.85%
8-K
Sep
Credit Facilities for ASP Acquisition
$5B in credit facilities ($2B revolving, $2B term loan, $1B 364-day) for $8.8B ASP acquisition
8-K
Aug
Q2 2025 Results
Rev $23.96B (+1.6% YoY), EPS $4.27 (+2.4% YoY)
10-Q
Aug
Acquired Foundation Building Materials
$8.8B cash acquisition deal
8-K
Aug
Q2 Earnings
Q2 ended August 1, 2025
8-K
Q2
4 filings
Jun
Annual Shareholder Meeting
All 12 directors elected, executive compensation approved, Deloitte ratified as auditor
8-K
May
Q1 2025 Results
Rev $20.9B (down 2.0% YoY), EPS $2.92 (down from $3.06 YoY)
10-Q
May
Q1 2025 Earnings
Q1 ended May 2, 2025 results announced
8-K
Apr
2025 Proxy Statement
CEO comp: Not disclosed, Say-on-pay: Advisory vote scheduled
DEF 14A
Q1
2 filings
Mar
FY2024 2025 Results
Rev data not available in extract, EPS data not available in extract
📌 Fiscal year ended January 31, 2025 - financial performance metrics not clearly extractable from provided XBRL taxonomy data
10-K
Feb
Q4 Earnings
Q4 and FY2025 results for period ended Jan 31, 2025
8-K
2024
Q4
3 filings
Dec
2024 Analyst and Investor Conference
Affirmed full year 2024 financial outlook, provided 2025 scenario planning
8-K
Nov
Q3 2024 Results
Rev $20.17B, EPS $2.99 (Rev down 1.5% YoY, EPS down 2.6% YoY)
10-Q
Nov
Q3 Earnings
Q3 2024 results for quarter ended Nov 1
8-K
Q3
2 filings
Aug
Q2 2024 Results
Rev $23.6B (-5.5% YoY), EPS $4.17 (-8.6% YoY)
10-Q
Aug
Q2 Earnings
Q2 2024 results for quarter ended August 2, 2024
8-K
Q2
4 filings
Jun
Annual Shareholder Meeting
All 13 directors elected, exec comp approved, Deloitte ratified as auditor
8-K
May
Q1 2024 Results
Rev $21.4B vs $22.3B (-4.4% YoY), EPS $3.06 vs $3.77 (-18.8% YoY)
10-Q
May
Q1 2024 Earnings
Q1 ended May 3, 2024 results
8-K
Apr
2024 Proxy Statement
Annual meeting: May 31, 2024, returned $8.9B to shareholders via buybacks/dividends in 2023
DEF 14A
Q1
2 filings
Mar
FY2023 Results
Unable to extract specific revenue and EPS figures from provided XBRL metadata
📌 Filed 10-K for fiscal year ended February 2, 2024, covering FY2023 performance period
10-K
Feb
Q4 Earnings
Q4 and FY2024 results for period ended Feb 2, 2024
8-K
2023
Q4
3 filings
Nov
Q3 2023 Results
Unable to extract specific revenue and EPS figures from provided XBRL data
10-Q
Nov
Q3 Earnings
Q3 ended Nov 3, 2023 results
8-K
Oct
Director Resigned
Daniel J. Heinrich resigned from Board effective Oct 23, 2023
8-K
Q3
2 filings
Sep
Credit Facility Amendment
$2B revolving credit facility, matures Sept 2028
8-K
Aug
Q2 2023 Results
Unable to extract specific revenue and EPS figures from XBRL data
10-Q